ph2

pharmaceutical industry is demanding cheaper and innovative CRM Pharma that will enable greater flexibility. CRM segments such as marketing automation, customer analytics and closed loop marketing will attract higher investments from pharmaceutical companies in the future. Management of key opinion leaders is another investment priority for pharmaceutical companies.

Sign up to get FREE CRM Trial

New analysis from Vision Tech CRM Pharma, Global Pharmaceutical CRM Markets, finds that only a flexible and cost-effective CRM Service can achieve strong penetration. The markets were estimated to grow at a CAGR of 4.9 percent from 2007 to 2014. The following segments are covered in the research: sales force automation, marketing automation, customer analytics, customer service, closed loop marketing and key opinion leaders management.

“There is an increasing demand for marketing automation and customer analytic tools,”. “Intensifying and escalating data are evoking interest in companies for the purpose of optimally analysing it to support improved decision making.”

ph2_2An evolving e-physician community is resulting in effortless communication and interaction with pharmaceutical companies. Pharmaceutical companies will take advantage of online physicians and patients; information gathering, storing and retrieving, analysing and reporting will become relatively easier. Accordingly, the demand for tools to perform these tasks will emerge as the next spending priority for pharmaceutical companies.

The global economic slowdown will restrain pharmaceutical companies, which will continue to cope with the existing infrastructure. This will delay spending on new technologies. CRM Pharma vendors will have a difficult time providing the right product mix for pharmaceutical companies.

To find out more about CRM Pharma, click here

contact-us-icons1

to conduct a free call.